Form 4: Pacific Biosciences Officer Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Michele Farmer, Chief Accounting Officer of Pacific Biosciences, sold shares to cover tax withholding obligations related to vesting restricted stock units.
Summary
- Michele Farmer, the Chief Accounting Officer of Pacific Biosciences of California, Inc., reported a transaction involving the sale of common stock on February 18, 2025.
- The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units.
- A total of 24,349 shares were sold at a weighted average price of $1.878 per share.
- Following the transaction, Farmer directly owns 187,592 shares of Pacific Biosciences common stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral. The transaction is a routine sale of shares to cover tax obligations, which is a common practice. There is no indication of any negative or positive implications for the company's performance.
Industry Context
Form 4 filings are standard disclosures required by the SEC when company insiders (officers, directors, or those holding more than 10% of a company's shares) buy or sell the company's stock. This filing indicates that a company insider has sold shares, which can sometimes be interpreted negatively by the market, although in this case, it's explicitly stated to cover tax obligations.
Stakeholder Impact
- The sale of shares by an officer could have a minor impact on shareholders, but it is unlikely to be significant given the stated reason for the sale.
Key Dates
| Date | Description |
|---|---|
| 02/18/2025 | Date of the stock sale transaction. |
| 02/19/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.